Canada markets closed

Valeo Pharma Inc. (VPHIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1050-0.0095 (-8.30%)
At close: 11:23AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.10M
Enterprise Value 51.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.25
Price/Book (mrq)N/A
Enterprise Value/Revenue 0.96
Enterprise Value/EBITDA -4.54

Trading Information

Stock Price History

Beta (5Y Monthly) 2.53
52-Week Change 3-71.25%
S&P500 52-Week Change 320.07%
52 Week High 30.4497
52 Week Low 30.1000
50-Day Moving Average 30.1281
200-Day Moving Average 30.1686

Share Statistics

Avg Vol (3 month) 3939
Avg Vol (10 day) 33.11k
Shares Outstanding 598.66M
Implied Shares Outstanding 699.75M
Float 845.29M
% Held by Insiders 147.12%
% Held by Institutions 17.24%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Oct 31, 2023
Most Recent Quarter (mrq)Jan 31, 2024

Profitability

Profit Margin -52.37%
Operating Margin (ttm)-35.92%

Management Effectiveness

Return on Assets (ttm)-23.07%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)54.29M
Revenue Per Share (ttm)0.62
Quarterly Revenue Growth (yoy)2.90%
Gross Profit (ttm)N/A
EBITDA -14.09M
Net Income Avi to Common (ttm)-28.43M
Diluted EPS (ttm)-0.2300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.59M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)66.36M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.49
Book Value Per Share (mrq)-0.48

Cash Flow Statement

Operating Cash Flow (ttm)-2.97M
Levered Free Cash Flow (ttm)-5.8M